DOCSLIB.ORG

List of Rare Diseases and Synonyms

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Marche des Maladies Rares – Alliance Maladies Rares DecemberJuly 2014 2009 List of rare diseases and synonyms Listed in alphabetical order www.orpha.net Rare diseases listed in alphabetical order ORPHA ORPHA ORPHA Disease name Disease name Disease name Number Number Number 289157 1-alpha-hydroxylase deficiency 66634 3-methylglutaconic aciduria type 5 2975 46,XX disorder of sex development - skeletal anomalies 79154 2-aminoadipic 2-oxoadipic aciduria 352328 3-methylglutaconic aciduria with deafness - encephalopathy - Leigh-like syndrome 243 46,XX gonadal dysgenesis 19 2-hydroxyglutaric acidemia 67046 3-methylglutaconyl-CoA hydratase 243 46,XX ovarian dysgenesis 19 2-hydroxyglutaric aciduria deficiency 2138 46,XX ovotesticular disorder of sex 391417 2-methyl-3-hydroxybutyric aciduria 67046 3MG-CoA hydratase deficiency development 391428 2-methyl-3-hydroxybutyric aciduria, 79351 3-phosphoglycerate dehydrogenase 2138 46,XX ovotesticular DSD classic type deficiency 243 46,XX pure gonadal dysgenesis 391428 2-methyl-3-hydroxybutyric aciduria, 79350 3-phosphoserine phosphatase deficiency infantile type 393 46,XX testicular disorder of sex 869 4A syndrome development 391457 2-methyl-3-hydroxybutyric aciduria, neonatal type 2118 4-alpha-hydroxyphenylpyruvate 393 46,XX testicular DSD hydroxylase deficiency 391417 2-methyl-3-hydroxybutyryl-CoA 199310 46,XX/46,XY chimerism dehydrogenase deficiency 88637 4H syndrome 242 46,XY CGD 391428 2-methyl-3-hydroxybutyryl-CoA 2118 4-HPPD deficiency 242 46,XY complete gonadal dysgenesis dehydrogenase deficiency, classic type 22 4-hydroxybutyric aciduria 96266 46,XY disorder of sex developement due 391428 2-methyl-3-hydroxybutyryl-CoA 2118 4-hydroxyphenylpyruvic acid dioxygenase to partial LH receptor inactivation dehydrogenase deficiency, infantile type deficiency 96266 46,XY disorder of sex developement due 391457 2-methyl-3-hydroxybutyryl-CoA 250977 5-amino-4-imidazole carboxamide to partial LH resistance dehydrogenase deficiency, neonatal type ribosiduria 96266 46,XY disorder of sex developement due 79095 2-methylacyl-CoA racemase deficiency 217064 5-fluorouracil intoxication to partial luteinizing hormone resistance 79157 2-methylbutyric aciduria 217064 5-fluorouracil poisoning 168558 46,XY disorder of sex development - 79157 2-methylbutyryl-CoA dehydrogenase adrenal insufficiency due to CYP11A1 33572 5-oxoprolinase deficiency deficiency deficiency 99135 6-phosphogluconate dehydrogenase 255182 2-oxoglutarate complex deficiency 752 46,XY disorder of sex development due to deficiency 17-beta-hydroxysteroid dehydrogenase 3 976 2,8-dihydroxyadenine urolithiasis 13 6-pyruvoyl-tetrahydropterin synthase deficiency 869 2A syndrome deficiency 753 46,XY disorder of sex development due to 869 3A syndrome 818 7-dehydrocholesterol reductase deficiency 5-alpha-reductase 2 deficiency 79301 3-beta-hydroxy-delta-5-C27-steroid 168588 11-beta-hydroxysteroid dehydrogenase 96265 46,XY disorder of sex development due to oxidoreductase deficiency deficiency type 1 complete LH receptor inactivation 7 3C syndrome 320 11-beta-hydroxysteroid dehydrogenase 96265 46,XY disorder of sex development due to deficiency type 2 20 3-hydroxy-3-methylglutaric aciduria complete LH resistance 752 17-beta-hydroxysteroid dehydrogenase 3 20 3-hydroxy-3-methylglutaryl-CoA lyase 96265 46,XY disorder of sex development due to deficiency deficiency complete luteinizing hormone receptor 752 17-ketoreductase deficiency inactivation 35701 3-hydroxy-3-methylglutaryl-CoA synthase deficiency 752 17-ketosteroidreductase deficiency 96265 46,XY disorder of sex development due to complete luteinizing hormone resistance 309127 3-hydroxyacyl-CoA dehydrogenase 99763 18-hydroxylase deficiency deficiency 90796 46,XY disorder of sex development due to 99763 18-oxidase deficiency isolated 17,20 lyase deficiency 939 3-hydroxyisobutyric aciduria 881 45,X syndrome 755 46,XY disorder of sex development due to 2616 3M syndrome 881 45,X/46,XX syndrome LH resistance or LHB deficiency 2616 3-M syndrome 1772 45,X/46,XY MGD 325448 46,XY disorder of sex development due to 293843 3MC syndrome LHB deficiency 1772 45,X/46,XY mixed gonadal dysgenesis 6 3-methylcrotonylglycinuria 755 46,XY disorder of sex development 1772 45,X0/46,XY MGD due to luteinizing hormone resistance 67046 3-methylglutaconic aciduria type 1 1772 45,X0/46,XY mixed gonadal dysgenesis or luteinizing hormone beta subunit 111 3-methylglutaconic aciduria type 2 deficiency 243 46,XX complete gonadal dysgenesis 67047 3-methylglutaconic aciduria type 3 2973 46,XX disorder of sex development - 67048 3-methylglutaconic aciduria type 4 anorectal anomalies Orphanet Report Series - List of rare diseases and synonyms listed in alphabetical number - July 2014 2 http://www.orpha.net/orphacom/cahiers/docs/GB/List_of_rare_diseases_in_alphabetical_order.pdf ORPHA ORPHA ORPHA Disease name Disease name Disease name Number Number Number 325448 46,XY disorder of sex development due 163693 2p21 microdeletion syndrome 96147 9q subtelomeric deletion syndrome to luteinizing hormone subunit beta 369881 2p21 microdeletion syndrome without 352665 9q21 microdeletion syndrome deficiency cystinuria 401923 9q31.1q31.3 microdeletion syndrome 96265 46,XY DSD due to complete LH receptor 228402 2q23.1 microdeletion syndrome inactivation 96147 9qSTDS 313947 2q23.1 microduplication syndrome 96265 46,XY DSD due to complete LH resistance 284169 10p11.21p12.31 microdeletion syndrome 1617 2q24 microdeletion syndrome 96265 46,XY DSD due to complete luteinizing 284169 10p12p11 microdeletion syndrome 251014 2q31.1 microdeletion syndrome hormone receptor inactivation 276413 10q22.3q23.3 microdeletion syndrome 294026 2q31.1 microduplication syndrome 96265 46,XY DSD due to complete luteinizing 276422 10q22.3q23.3 microduplication syndrome hormone resistance 251019 2q32q33 microdeletion syndrome 1307 10q24 microduplication syndrome 755 46,XY DSD due to LH resistance or LHB 251019 2q32-q33 microdeletion syndrome deficiency 52022 11p11.2 deletion 251028 2q33.1 microdeletion syndrome 325448 46,XY DSD due to LHB deficiency 300305 11p15.4 microduplication syndrome 1001 2q37 microdeletion syndrome 755 46,XY DSD due to luteinizing hormone 313884 12p12.1 microdeletion syndrome 65286 3q subtelomere deletion syndrome resistance or luteinizing hormone beta 280325 12p13.33 microdeletion syndrome subunit deficiency 1621 3q13 microdeletion syndrome 94063 12q14 microdeletion syndrome 325448 46,XY DSD due to luteinizing hormone 96095 3q26 microduplication syndrome subunit beta deficiency 289513 12q15q21.1 microdeletion syndrome 356947 3q26q27 microdeletion syndrome 96266 46,XY DSD due to partial LH receptor 1590 13q32 deletion 356947 3q26-q27microdeletion syndrome inactivation 261120 14q11.2 microdeletion syndrome 397695 3q27.3 microdeletion syndrome 96266 46,XY DSD due to partial LH resistance 261229 14q11.2 microduplication syndrome 65286 3q29 microdeletion syndrome 96266 46,XY DSD due to partial luteinizing 261144 14q12 microdeletion syndrome hormone resistance 251038 3q29 microduplication 264200 14q22q23 microdeletion syndrome 168563 46,XY gonadal dysgenesis - motor and 65286 3qter deletion sensory neuropathy 264200 14q22-q23 microdeletion syndrome 280 4p- syndrome 325345 46,XY ovotesticular disorder of sex 401935 14q24.1q24.3 microdeletion syndrome 96072 4p16.3 microduplication syndrome development 314585 15q overgrowth syndrome 238750 4q21 microdeletion syndrome 325345 46,XY ovotesticular DSD 261183 15q11.2 microdeletion syndrome 329802 5p13 microduplication syndrome 251510 46,XY partial gonadal dysgenesis 238446 15q11q13 duplication syndrome 86841 5q- syndrome 251510 46,XY partial testicular dysgenesis 238446 15q11-q13 duplication syndrome 228384 5q14.3 microdeletion syndrome 251510 46,XY PGD 238446 15q11q13 microduplication syndrome 314655 5q31.3 microdeletion syndrome 242 46,XY pure gonadal dysgenesis 238446 15q11-q13 microduplication syndrome 228415 5q35 microduplication syndrome 3375 47,XXX syndrome 199318 15q13.3 microdeletion syndrome 96125 6p subtelomeric deletion syndrome 8 47,XYY syndrome 261190 15q14 microdeletion syndrome 251046 6p22 microdeletion syndrome 9 48,XXXX syndrome 94065 15q24 microdeletion syndrome 96125 6p25 microdeletion syndrome 96263 48,XXXY syndrome 1596 15q26 deletion 75857 6q terminal deletion syndrome 10 48,XXYY syndrome 363992 15q26.3 microdeletion syndrome 171829 6q16 deletion syndrome 99329 48,XYYY syndrome 261211 16p11.2p12.2 microdeletion syndrome 251056 6q25 microdeletion syndrome 11 49,XXXXX syndrome 261211 16p11.2-p12.2 microdeletion syndrome 314034 7p22.1 microduplication syndrome 96264 49,XXXXY syndrome 261204 16p11.2p12.2 microduplication syndrome 96121 7q11.23 microduplication syndrome 261534 49,XXXYY syndrome 261236 16p13.11 microdeletion syndrome 251061 7q31 microdeletion syndrome 99330 49,XYYYY syndrome 261243 16p13.11 microduplication syndrome 96092 8p inverted duplication/deletion 293948 1p21.3 microdeletion syndrome 96078 16p13.3 microduplication syndrome syndrome 401986 1p31p32 microdeletion syndrome 352629 16q24.1 microdeletion syndrome 168953 8p11 myeloproliferative syndrome 1606 1p36 deletion syndrome 261250 16q24.3 microdeletion syndrome 251066 8p11.2 deletion syndrome 250989 1q21.1 microdeletion syndrome 819 17p11.2 microdeletion 251071 8p23.1 microdeletion syndrome 250994 1q21.1 microduplication syndrome 1713 17p11.2 microduplication syndrome 251076 8p23.1 microduplication syndrome 250999 1q41q42 microdeletion syndrome 217385 17p13.3 duplication syndrome 228399 8q12 microduplication syndrome 250999
Recommended publications
  • IDF Patient & Family Handbook

    IDF Patient & Family Handbook

    Immune Deficiency Foundation Patient & Family Handbook for Primary Immunodeficiency Diseases This book contains general medical information which cannot be applied safely to any individual case. Medical knowledge and practice can change rapidly. Therefore, this book should not be used as a substitute for professional medical advice. FIFTH EDITION COPYRIGHT 1987, 1993, 2001, 2007, 2013 IMMUNE DEFICIENCY FOUNDATION Copyright 2013 by Immune Deficiency Foundation, USA. REPRINT 2015 Readers may redistribute this article to other individuals for non-commercial use, provided that the text, html codes, and this notice remain intact and unaltered in any way. The Immune Deficiency Foundation Patient & Family Handbook may not be resold, reprinted or redistributed for compensation of any kind without prior written permission from the Immune Deficiency Foundation. If you have any questions about permission, please contact: Immune Deficiency Foundation, 110 West Road, Suite 300, Towson, MD 21204, USA; or by telephone at 800-296-4433. Immune Deficiency Foundation Patient & Family Handbook for Primary Immunodeficency Diseases 5th Edition This publication has been made possible through a generous grant from Baxalta Incorporated Immune Deficiency Foundation 110 West Road, Suite 300 Towson, MD 21204 800-296-4433 www.primaryimmune.org [email protected] EDITORS R. Michael Blaese, MD, Executive Editor Francisco A. Bonilla, MD, PhD Immune Deficiency Foundation Boston Children’s Hospital Towson, MD Boston, MA E. Richard Stiehm, MD M. Elizabeth Younger, CPNP, PhD University of California Los Angeles Johns Hopkins Los Angeles, CA Baltimore, MD CONTRIBUTORS Mark Ballow, MD Joseph Bellanti, MD R. Michael Blaese, MD William Blouin, MSN, ARNP, CPNP State University of New York Georgetown University Hospital Immune Deficiency Foundation Miami Children’s Hospital Buffalo, NY Washington, DC Towson, MD Miami, FL Francisco A.
  • Isolated Acrania in the Presence of Amniotic Band Syndrome

    Isolated Acrania in the Presence of Amniotic Band Syndrome

    100 Jul 2017 Vol 10 No.3 North American Journal of Medicine and Science Case Report Isolated Acrania in the Presence of Amniotic Band Syndrome Lei Li, MD, PhD; Sandra Cerda, MD; David Kindelberger, MD; Jing Yang, MD, PhD; Carmen Sarita-Reyes, MD* Department of Pathology and Laboratory Medicine, Boston Medical Center, Boston, MA Acrania is an extremely rare congenital developmental anomaly. It is often confused with another disease entity, anencephaly. Even though these two developmental defects often occur simultaneously, they are believed to have different pathogenic mechanisms. We report the case of a 22-year-old woman with an unremarkable first trimester pregnancy who delivered a demised male fetus at 16 weeks gestation. External and microscopic examination of the fetus revealed normal development in all internal organs. The brain was covered by leptomeninges only, with an absence of skull and overlying skin. Additionally, both the fetus and placenta showed evidence of amniotic band syndrome. A diagnosis of isolated acrania in the presence of amniotic band syndrome was made. The exact etiology of acrania is not well understood. Two popular theories suggest that amniotic bands or a migration failure of the ectodermal mesenchyme may play a role in the pathogenesis. We believe that isolated acrania may represent a group of developmental anomalies which share a common ultimate outcome: absence of the neurocranium with relatively minor effects on brain development. [N A J Med Sci. 2017;10(3):100-102. DOI: 10.7156/najms.2017.1003100] Key Words: acrania, anencephaly, acalvaria, amniotic band syndrome INTRODUCTION Acrania is an extremely rare lethal embryonic developmental current smoker.
  • Primary Liver Cancer: Epidemiological And

    Primary Liver Cancer: Epidemiological And

    PRIMARY LIVER CANCER: EPIDEMIOLOGICAL AND BIOMARKER DISCOVERY STUDIES Nimzing Gwamzhi Ladep Imperial College London Department of Medicine December 2013 Thesis submitted for Doctor of Philosophy 1 THESIS ABSTRACT With previous reports indicating changes in mortality, risk factors and management of primary liver cancer (PLC), evaluation of current trends in the incidence and mortality rates was indicated. Late diagnosis has been implicated to be a major contributor to the high fatality rates of PLC. This work aimed at: studying trends of PLC by subcategories globally in general, and in England and Wales, in particular; investigating liver-related morbidities of HIV infected patients in an African setting; and discovering urinary biomarkers of hepatocellular carcinoma. The World Health Organisation (WHO) and Small Area Health Statistics Unit (SAHSU) databases were interrogated respectively, in order to achieve the first aim. The second aim was achieved through utilisation of databases of an African-based HIV treatment programme- AIDS Prevention Initiative in Nigeria (APIN), located in Jos, Nigeria. The European Union-funded Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) case-control study in three West African countries was the platform through which urinary metabolic profiling was accomplished. Proton nuclear magnetic resonance spectroscopy (NMR) and parallel ultra-performance liquid chromatography mass spectrometry (UPLC-MS) were used for biomarker discovery studies. Mortality rates of intrahepatic bile duct carcinoma (IHBD) increased in all countries that were studied. Misclassification of hilar cholangiocarcinoma accounted for only a small increase in the rate of IHBD in England and Wales. With over 90% screening rate for viral hepatitides, the rates of hepatitis B (HBV), hepatitis C (HCV) and 2 HBV/HCV in HIV-infected patients in the APIN programme were 17.8%, 11.3% and 2.5% respectively.
  • Repercussions of Inborn Errors of Immunity on Growth☆ Jornal De Pediatria, Vol

    Repercussions of Inborn Errors of Immunity on Growth☆ Jornal De Pediatria, Vol

    Jornal de Pediatria ISSN: 0021-7557 ISSN: 1678-4782 Sociedade Brasileira de Pediatria Goudouris, Ekaterini Simões; Segundo, Gesmar Rodrigues Silva; Poli, Cecilia Repercussions of inborn errors of immunity on growth☆ Jornal de Pediatria, vol. 95, no. 1, Suppl., 2019, pp. S49-S58 Sociedade Brasileira de Pediatria DOI: https://doi.org/10.1016/j.jped.2018.11.006 Available in: https://www.redalyc.org/articulo.oa?id=399759353007 How to cite Complete issue Scientific Information System Redalyc More information about this article Network of Scientific Journals from Latin America and the Caribbean, Spain and Journal's webpage in redalyc.org Portugal Project academic non-profit, developed under the open access initiative J Pediatr (Rio J). 2019;95(S1):S49---S58 www.jped.com.br REVIEW ARTICLE ଝ Repercussions of inborn errors of immunity on growth a,b,∗ c,d e Ekaterini Simões Goudouris , Gesmar Rodrigues Silva Segundo , Cecilia Poli a Universidade Federal do Rio de Janeiro (UFRJ), Faculdade de Medicina, Departamento de Pediatria, Rio de Janeiro, RJ, Brazil b Universidade Federal do Rio de Janeiro (UFRJ), Instituto de Puericultura e Pediatria Martagão Gesteira (IPPMG), Curso de Especializac¸ão em Alergia e Imunologia Clínica, Rio de Janeiro, RJ, Brazil c Universidade Federal de Uberlândia (UFU), Faculdade de Medicina, Departamento de Pediatria, Uberlândia, MG, Brazil d Universidade Federal de Uberlândia (UFU), Hospital das Clínicas, Programa de Residência Médica em Alergia e Imunologia Pediátrica, Uberlândia, MG, Brazil e Universidad del Desarrollo,
  • Genes in Eyecare Geneseyedoc 3 W.M

    Genes in Eyecare Geneseyedoc 3 W.M

    Genes in Eyecare geneseyedoc 3 W.M. Lyle and T.D. Williams 15 Mar 04 This information has been gathered from several sources; however, the principal source is V. A. McKusick’s Mendelian Inheritance in Man on CD-ROM. Baltimore, Johns Hopkins University Press, 1998. Other sources include McKusick’s, Mendelian Inheritance in Man. Catalogs of Human Genes and Genetic Disorders. Baltimore. Johns Hopkins University Press 1998 (12th edition). http://www.ncbi.nlm.nih.gov/Omim See also S.P.Daiger, L.S. Sullivan, and B.J.F. Rossiter Ret Net http://www.sph.uth.tmc.edu/Retnet disease.htm/. Also E.I. Traboulsi’s, Genetic Diseases of the Eye, New York, Oxford University Press, 1998. And Genetics in Primary Eyecare and Clinical Medicine by M.R. Seashore and R.S.Wappner, Appleton and Lange 1996. M. Ridley’s book Genome published in 2000 by Perennial provides additional information. Ridley estimates that we have 60,000 to 80,000 genes. See also R.M. Henig’s book The Monk in the Garden: The Lost and Found Genius of Gregor Mendel, published by Houghton Mifflin in 2001 which tells about the Father of Genetics. The 3rd edition of F. H. Roy’s book Ocular Syndromes and Systemic Diseases published by Lippincott Williams & Wilkins in 2002 facilitates differential diagnosis. Additional information is provided in D. Pavan-Langston’s Manual of Ocular Diagnosis and Therapy (5th edition) published by Lippincott Williams & Wilkins in 2002. M.A. Foote wrote Basic Human Genetics for Medical Writers in the AMWA Journal 2002;17:7-17. A compilation such as this might suggest that one gene = one disease.
  • RD-Action Matchmaker – Summary of Disease Expertise Recorded Under

    RD-Action Matchmaker – Summary of Disease Expertise Recorded Under

    Summary of disease expertise recorded via RD-ACTION Matchmaker under each Thematic Grouping and EURORDIS Members’ Thematic Grouping Thematic Reported expertise of those completing the EURORDIS Member perspectives on Grouping matchmaker under each heading Grouping RD Thematically Rare Bone Achondroplasia/Hypochondroplasia Achondroplasia Amelia skeletal dysplasia’s including Achondroplasia/Growth hormone cleidocranial dysostosis, arthrogryposis deficiency/MPS/Turner Brachydactyly chondrodysplasia punctate Fibrous dysplasia of bone Collagenopathy and oncologic disease such as Fibrodysplasia ossificans progressive Li-Fraumeni syndrome Osteogenesis imperfecta Congenital hand and fore-foot conditions Sterno Costo Clavicular Hyperostosis Disorders of Sex Development Duchenne Muscular Dystrophy Ehlers –Danlos syndrome Fibrodysplasia Ossificans Progressiva Growth disorders Hypoparathyroidism Hypophosphatemic rickets & Nutritional Rickets Hypophosphatasia Jeune’s syndrome Limb reduction defects Madelung disease Metabolic Osteoporosis Multiple Hereditary Exostoses Osteogenesis imperfecta Osteoporosis Paediatric Osteoporosis Paget’s disease Phocomelia Pseudohypoparathyroidism Radial dysplasia Skeletal dysplasia Thanatophoric dwarfism Ulna dysplasia Rare Cancer and Adrenocortical tumours Acute monoblastic leukaemia Tumours Carcinoid tumours Brain tumour Craniopharyngioma Colon cancer, familial nonpolyposis Embryonal tumours of CNS Craniopharyngioma Ependymoma Desmoid disease Epithelial thymic tumours in
  • Acalvaria: Case Report and Review of Literature of a Rare

    Acalvaria: Case Report and Review of Literature of a Rare

    DOI: 10.7860/JCDR/2018/35736.11530 Case Report Acalvaria: Case Report and Review of Literature of a Rare Paediatrics Section Congenital Malformation DEEKSHA ANAND SINGLA1, ANAND SINGLA2 ABSTRACT Acalvaria, defined as absent skull bones, is an extremely rare congenital anomaly with only a handful of cases reported in literature. Hypocalvaria is its hypoplastic variant where the skull bones are incompletely formed. Due to such a rare incidence, it has been given the status of an orphan disease. In this report we present the case of a female neonate with acalvaria born in our institute. The neonate survived a short and stormy course of 12 days as she also had associated co-morbidities. The condition per se has been described as having high mortality rate. Very few living cases, less than ten have been reported till date. Keywords: Absent skull bones, Hypocalvaria, Orphan disease CASE REPORT admitted in view of bad obstetric history. An emergency cesarean The baby (female) was born to a 25-year-old female by non section had to be undertaken as she developed fetal distress. consanguineous marriage through spontaneous conception. The The index female neonate was born by caesarean section at 34 birth order of the baby was fifth and the only surviving sibling was a weeks of gestation. APGAR Score at one and five minutes was nine five-year-old female. The first baby was a male, born 10 years back each. The heart rate was 142 beats per minute, respiratory rate through normal vaginal delivery who died at 1.5 months of age, was 66 breaths per minute with mild subcostal and intercostals the cause of death was unknown to the parents.
  • Instelling Naam Expertise Centrum Cluster Van / Specifieke Aandoening Toelichting Erkenning

    Instelling Naam Expertise Centrum Cluster Van / Specifieke Aandoening Toelichting Erkenning

    Instelling Naam Expertise Centrum Cluster van / Specifieke aandoening Toelichting erkenning AMC Amsterdam Lysosome Center Gaucher disease ("Sphinx") Fabry disease Niemann-Pick disease type A Niemann-Pick disease type B Niemann-Pick disease type C Mucopolysaccharidosis type 1 Mucopolysaccharidosis type 3 Mucopolysaccharidosis type 4 Lysosomal Disease Cholesteryl ester storage disease AMC Dutch Centre for Peroxisomal Peroxisome biogenesis disorder-Zellweger syndrome spectrum disorders Disorder of peroxisomal alpha- - beta- and omega-oxidation Rhizomelic chondrodysplasia punctata Non-syndromic pontocerebellar hypoplasia AMC Expertise center Vascular medicine Homozygous familial hypercholesterolemia Familial lipoprotein lipase deficiency Tangier disease AMC Centre for Genetic Metabolic Disorder of galactose metabolism Diseases Amsterdam Disorder of phenylalanine metabolism AMC Centre for Neuromuscular Diseases Neuromuscular disease Motor neuron disease; amyotrophic lateral sclerosis, primary sclerosis and progressive muscular atrophy Idiopathic inflammatory myopathy, incl dermatomyositis, polymyositis, necrotizing autoimmune myopathy and inclusion body myositis Poliomyelitis Hereditary motor and sensory neuropathy Chronic inflammatory demyelinating polyneuropathy, incl. Guillain_Barre syndrome, CIDP, MMN AMC Centre for rare thyroid diseases Congenital hypothyroidism AMC Centre for gastroenteropancreatic Gastroenteropancreatic endocrine tumor neuroendocrine tumors AMC Centre for rare hypothalamic and Rare hypothalamic or pituitary disease pituitary
  • Prevalence and Incidence of Rare Diseases: Bibliographic Data

    Prevalence and Incidence of Rare Diseases: Bibliographic Data

    Number 1 | January 2019 Prevalence and incidence of rare diseases: Bibliographic data Prevalence, incidence or number of published cases listed by diseases (in alphabetical order) www.orpha.net www.orphadata.org If a range of national data is available, the average is Methodology calculated to estimate the worldwide or European prevalence or incidence. When a range of data sources is available, the most Orphanet carries out a systematic survey of literature in recent data source that meets a certain number of quality order to estimate the prevalence and incidence of rare criteria is favoured (registries, meta-analyses, diseases. This study aims to collect new data regarding population-based studies, large cohorts studies). point prevalence, birth prevalence and incidence, and to update already published data according to new For congenital diseases, the prevalence is estimated, so scientific studies or other available data. that: Prevalence = birth prevalence x (patient life This data is presented in the following reports published expectancy/general population life expectancy). biannually: When only incidence data is documented, the prevalence is estimated when possible, so that : • Prevalence, incidence or number of published cases listed by diseases (in alphabetical order); Prevalence = incidence x disease mean duration. • Diseases listed by decreasing prevalence, incidence When neither prevalence nor incidence data is available, or number of published cases; which is the case for very rare diseases, the number of cases or families documented in the medical literature is Data collection provided. A number of different sources are used : Limitations of the study • Registries (RARECARE, EUROCAT, etc) ; The prevalence and incidence data presented in this report are only estimations and cannot be considered to • National/international health institutes and agencies be absolutely correct.
  • Orphanet Report Series Rare Diseases Collection

    Orphanet Report Series Rare Diseases Collection

    Marche des Maladies Rares – Alliance Maladies Rares Orphanet Report Series Rare Diseases collection DecemberOctober 2013 2009 List of rare diseases and synonyms Listed in alphabetical order www.orpha.net 20102206 Rare diseases listed in alphabetical order ORPHA ORPHA ORPHA Disease name Disease name Disease name Number Number Number 289157 1-alpha-hydroxylase deficiency 309127 3-hydroxyacyl-CoA dehydrogenase 228384 5q14.3 microdeletion syndrome deficiency 293948 1p21.3 microdeletion syndrome 314655 5q31.3 microdeletion syndrome 939 3-hydroxyisobutyric aciduria 1606 1p36 deletion syndrome 228415 5q35 microduplication syndrome 2616 3M syndrome 250989 1q21.1 microdeletion syndrome 96125 6p subtelomeric deletion syndrome 2616 3-M syndrome 250994 1q21.1 microduplication syndrome 251046 6p22 microdeletion syndrome 293843 3MC syndrome 250999 1q41q42 microdeletion syndrome 96125 6p25 microdeletion syndrome 6 3-methylcrotonylglycinuria 250999 1q41-q42 microdeletion syndrome 99135 6-phosphogluconate dehydrogenase 67046 3-methylglutaconic aciduria type 1 deficiency 238769 1q44 microdeletion syndrome 111 3-methylglutaconic aciduria type 2 13 6-pyruvoyl-tetrahydropterin synthase 976 2,8 dihydroxyadenine urolithiasis deficiency 67047 3-methylglutaconic aciduria type 3 869 2A syndrome 75857 6q terminal deletion 67048 3-methylglutaconic aciduria type 4 79154 2-aminoadipic 2-oxoadipic aciduria 171829 6q16 deletion syndrome 66634 3-methylglutaconic aciduria type 5 19 2-hydroxyglutaric acidemia 251056 6q25 microdeletion syndrome 352328 3-methylglutaconic
  • Print This Article

    Print This Article

    International Journal of Research in Medical Sciences Lekha KS et al. Int J Res Med Sci. 2021 Feb;9(2):364-370 www.msjonline.org pISSN 2320-6071 | eISSN 2320-6012 DOI: https://dx.doi.org/10.18203/2320-6012.ijrms20210050 Original Research Article Genital ambiguity: a cytogenetic evaluation of gender K. S. Lekha1*, V. Bhagyam2, P. D. Varghese3, M. Manju2 1Department of Anatomy, Government Medical College Thrissur, Kerala, India 2Department of Anatomy, Government Medical College Kozhikode, Kerala, India 3Department of Anatomy, Government Medical College Alappuzha, Kerala, India Received: 15 December 2020 Accepted: 31 December 2020 *Correspondence: Dr. K. S. Lekha, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Background: Genital ambiguity is a complex genetic disorder of sexual differentiation into male or female. The purpose of the present study is to correlate the sex of rearing with the genetic sex and to find out the prevalence of chromosomal anomalies in patients with ambiguous genitalia. The findings can help in proper diagnosis, genetic counselling, and the reassignment of sex, if necessary. Methods: In this cross-sectional study, 22 patients from north Kerala, ranging in age from 17 days to 17 years, were included. All cases were subjected to the following: a detailed history, physical examination, evaluation of clinical data, and cytogenetic analysis. Based on the standard protocol, peripheral blood lymphocyte culture was done.
  • 7-Nose II.Docx ( Updated F1 )

    7-Nose II.Docx ( Updated F1 )

    1 [Color index: Important | Notes | Extra] Editing ​ ​ ​ ​ ​ ​ ​ ​ 2 Diseases of the nose Supernumerary nostril Midline nasal sinus: Nasal clefts: Proboscis lateralis: Incomplete fusion of the right Failure of frontal nasal Due to imperfect fusion and left medial nasal process to develop between the maxillary process prominence. appropriately results into and the lateral nasal process. two separated halves of the nose. Polyrrhinia: Arrhinia: due to bilateral Half nose: due to unilateral absence of nasal placode ​ ​ Duplication of the medial nasal absence of nasal placodes. processes. This is serious because the newborn is a nose breather. mouth breathing is a learning process. Atresia of posterior nares ❖ Types: ● Bony (most commonly) ● Membranous ● Mixed ● Complete unilateral (most commonly) ● Complete bilateral surgical emergency ​ ● Incomplete unilateral ● Incomplete bilateral ❖ Diagnosis: ● Total absence of nasal air flow ● Plastic catheter cannot be passed through the nose ● Post-rhinoscopy ● Radiographs 3 ● Emergency ● Transnasal perforation ● Trans-palatal excision ❖ Management: ﻧﻔﺘﺢ ﻓﻤﻪ ﻓﯿﻀﻄﺮ ﯾﺘﻨﻔﺲ ﻣﻦ ﻓﻤﻪ (Put something to open the mouth (oral airway ● ● Perforate it If membranous ● Surgery (endoscopic) ● In bilateral it is an emergency, in unilateral it is not an emergency and we can wait until the child gains weight then we do surgery. ● Rhinitis refers to inflammatory changes in the nasal mucosa. As the nasal mucosa is continuous ​ ​ ​ ​ ​ ​ over the nose and sinuses, there is nearly always some inflammatory change in the sinuses as 1 well. Hence Rhinosinusitis is​ a better term. ● Types: - acute rhinitis (less than 4 weeks) - chronic rhinitis (more than four consecutive weeks) ● Types based on etiology: 1) Infectious rhinitis(viral/bacterial) 2)Non-allergic Rhinitis,Non-infectious rhinitis -Eosinophilic syndromes(Nares/Nasal polyposis) -NonEosinophilic syndromes(Vasomotor rhinitis/Rhinitis medicamentosa/occupational rhinitis/Rhinitis of pregnancy/hypothyroidism/Medication(OCP).